What is hemophilia C?

Hemophilia C is a bleeding disorder in which a person is missing or missing a factor of CRC XI. Coating factors help coagulate blood and thus control or stop bleeding. A person who has a failure then experiences excessive or prolonged bleeding. Hemophilia C is mainly an autosomal recessive disorder, which means that both parents must be a recessive gene wearer, and each must give the child to a disorder. The disorder itself is also known as the lack of factor XI, plasma thromboplastin deficiencies (PTA) or Rosenthal syndrome. Unlike haemophilia A and B, which are more common types of haemophilia, haemophilia C affects both men and women as well. Like haemophilia A and B, anyone from any ethnicity or race of haemophilia C can have.

Although it depends on the specific state of man, the symptoms of haemophilia C are generally mild compared to other types of haemophilia. Forts of bleeding tend to be unforeseenElne. There are bruises and nose bleeding, but are rare, as well as joint bleeding and spontaneous bleeding. Excessive or prolonged bleeding usually happens after a major event such as childbirth, surgery or trauma. It can be during this main event when one first finds that he has a disorder.

The diagnosis of haemophilia C may include a number of tests. Test examples include a bleeding test, a partial thromboplastin (APTT) and Protrombin (PT) test. In addition, another way to diagnose a failure is a test of factor activity XI. Along with these tests, it also helps to diagnose family bleeding, as it is an inherited disorder.

There is no cure for haemophilia C; It's a lifelong disorder. In general, however, a person with a condition can live a normal life and requires no type of therapy or treatment unless it experiences an extended episode of bleeding, for exampleafter surgery. In this case, treatment would consist of plasma infusion. The amount of plasma infunded during the procedure can be large to ensure sufficient XI factor transmission. Another type of treatment, specifically for bleeding from the mouth, is the use of antifibrinolytic substances.